Sort
8,912 grants matching “sars cov 2”
North Carolina Seronet Center for Excellence
$2,950,055Ralph S Baric · Univ Of North Carolina Chapel Hill · U54 · FY2023 · CA
ACE2 immunodecoys for long-lasting immunoprophylaxis against sarbecovirus and merbecoviruses that target human ACE2
$2,937,578Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
Stony Brook University Laboratory for Comparative Medicine to Support Pandemic Preparedness
$2,933,079David G Thanassi · State University New York Stony Brook · G20 · FY2022 · AI
CEIRS - SARS-CoV-2 RESEARCH
$2,929,356John Jay Treanor · University Of Rochester · N01 · FY2020 · AI
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2 THERAPEUTICS RESEARCH RELATED ACTIVITIES
$2,924,707Timothy Stedman · American Type Culture Collection · N01 · FY2022 · AI
Targeting viral envelopes with antiviral peptides and peptoids and degraders, and surface proteins with small molecules
$2,909,919Nam-Joon Cho · Stanford University · U19 · FY2022 · AI
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
$2,906,437Leah Helane Rubin · Johns Hopkins University · RF1 · FY2023 · MH
1/2 REPRIEVE Extension for Trial Completion
$2,903,944Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2025 · HL
Discovery of novel broad-spectrum coronavirus inhibitors
$2,888,994Vineet D Menachery · University Of Texas Med Br Galveston · U19 · FY2022 · AI
Project 3: Pandemic Virus Protease Inhibitors
$2,879,997Reuben S Harris · University Of Minnesota · U19 · FY2022 · AI
Research Resources and Workforce Development for the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University
$2,877,411Karen Marie Dobos · Colorado State University · UC7 · FY2024 · AI
NIH StrokeNet National Clinical Coordinating Center (NCC)
$2,863,371Pooja Khatri · University Of Cincinnati · U01 · FY2024 · NS
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
$2,861,642William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Drug Repurposing Screening for Rare and Neglected Diseases
$2,859,284Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
$2,856,790William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Core D - Genomics
$2,841,208Alexander L Greninger · Emory University · U19 · FY2022 · AI
Project 2: PanbetaCoV protein vaccine design
$2,828,814Kevin Wiehe · Duke University · P01 · FY2023 · AI
Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention
$2,820,494Robert Rodick · Vxbiosciences, Inc. · R01 · FY2021 · AI
Design and evaluation of pan-CoV vaccines
$2,819,456Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2023 · AI
Core F â High-Throughput Screening
$2,817,180Robert Marsden Cox · Emory University · U19 · FY2022 · AI
COVID-19 SARS-COV-2 PROPAGATION AND PATHOLOGY AND MITOCHONDRIAL GENETICS
$2,816,000The Children'S Hospital Of Philadelphia · · FY2021 · Defense Health Agency
Core 3: Non-human Primate Core
$2,798,848Barton F Haynes · Duke University · P01 · FY2023 · AI
Tulane University COVID Antibody and Immunity Network (TUCAIN)
$2,792,292James E Robinson · Tulane University Of Louisiana · U54 · FY2023 · CA
Telehealth policy expansion's impact on patient care & mental health
$2,790,468Lucinda B Leung · University Of California Los Angeles · RF1 · FY2023 · MH
Allergic sensitization through the airway
$2,788,618Donald N Cook · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES